Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Merck Kgaa ADR (MKKGY)

Merck Kgaa ADR (MKKGY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.8100 +1.29%
on 12/03/19
24.3200 -5.00%
on 11/12/19
-0.7600 (-3.18%)
since 11/05/19
3-Month
20.6100 +12.11%
on 09/10/19
24.3200 -5.00%
on 11/12/19
+1.6380 (+7.63%)
since 09/05/19
52-Week
19.2000 +20.34%
on 05/31/19
24.3200 -5.00%
on 11/12/19
+0.9100 (+4.10%)
since 12/04/18

Most Recent Stories

More News
Ping An Good Doctor and Merck KGaA, Darmstadt, Germany Form Strategic Collaboration to Advance Intelligent Healthcare in China

Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK) one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today...

MKKGY : 23.1300 (+0.11%)
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) for its...

MKKGY : 23.1300 (+0.11%)
Merck KGaA, Darmstadt, Germany, Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations

DARMSTADT, Germany , Nov. 20, 2019 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany , a leading science and technology company, today announced that the Japanese Ministry of Health, Labour and...

MKKGY : 23.1300 (+0.11%)
Personalis, Inc. Announces Collaboration With Merck KGaA, Darmstadt, Germany, to Identify and Develop Novel Biomarkers for Cancer Therapies

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced a collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to investigate novel...

MKKGY : 23.1300 (+0.11%)
PSNL : 9.02 (+2.62%)
Oxford BioDynamics' EpiSwitch(TM) Featured in Presentations on Development and Validation of Blood-Based Predictive Biomarkers in Immune Checkpoint Inhibitor Programs

Oxford BioDynamics Plc (AIM: OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers for the pharmaceutical and biotechnology industry, today announced that data...

MKKGY : 23.1300 (+0.11%)
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study...

MKKGY : 23.1300 (+0.11%)
PFE : 38.42 (+1.03%)
Medisafe Announces Strong Results from Digital Medication Management Programs

Medisafe, an evidence-based digital therapeutics company providing medication management solutions for patients across the healthcare continuum, and Merck KGaA, Darmstadt, Germany, a vibrant science and...

MKKGY : 23.1300 (+0.11%)
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved BAVENCIO®...

MKKGY : 23.1300 (+0.11%)
PFE : 38.42 (+1.03%)
TraceLink Appoints Merck KGaA Thought Leader to Drive Strategy for Deployment of Advanced Analytics across Life Sciences Industry

TraceLink Inc., the world's largest integrated digital supply network providing real-time information sharing for better patient outcomes, today announced that Bharath Sundararaman has joined the Company...

MKKGY : 23.1300 (+0.11%)
EMD Serono Announces JAMA Publication of Phase II Results of Sprifermin for Osteoarthritis Structure Modification

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that results from FORWARD, a five-year, multicenter Phase II study of sprifermin, a...

MKKGY : 23.1300 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MKKGY with:

Key Turning Points

2nd Resistance Point 23.1883
1st Resistance Point 23.1467
Last Price 23.1300
1st Support Level 23.0567
2nd Support Level 23.0083

See More

52-Week High 24.3200
Last Price 23.1300
Fibonacci 61.8% 22.3642
Fibonacci 50% 21.7600
Fibonacci 38.2% 21.1558
52-Week Low 19.2000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar